Medical Condition News

RSS

Brain-machine interfaces could one day help patients who have lost speaking ability

New Caltech research is showing how devices implanted into people's brains, called brain-machine interfaces (BMIs), could one day help patients who have lost their ability to speak.

14 Nov 2022

Mechanically active adhesive prevents and supports the recovery from muscle atrophy

Muscles waste as a result of not being exercised enough, as happens quickly with a broken limb that has been immobilized in a cast, and more slowly in people reaching an advanced age.

14 Nov 2022

PALS program effective in ensuring diverse representation in lupus clinical trials

The Lupus Research Alliance and its affiliate Lupus Therapeutics presented data at ACR Convergence 2022 with results showing the effectiveness of a pilot peer education program called the Patient Advocates for Lupus Studies (PALS), in increasing knowledge, perception, and willingness among people with Systemic Lupus Erythematosus (SLE) to participate in clinical trials.

14 Nov 2022

Study highlights the complexity of health-care costs for ADRD patients who develop delirium

Alzheimer's Dementia and Related Disorders (ADRD) affects upwards of 5 million people in the United States, with no known treatments to stop or prevent its progression.

14 Nov 2022

Mast cells in synovial tissue may explain why women report worse osteoarthritis pain than men

Investigators at Hospital for Special Surgery (HSS) have discovered that at the time of total knee replacement, women have significantly increased levels of immune cells called mast cells in synovial tissue surrounding the knee joint than men.

14 Nov 2022

Study finds a positive impact of exercise on the gut microbiome of cancer patients

Regular physical activity can extend colorectal cancer patients' lives. In a first-ever study, scientists looked at the impact of exercise on the gut microbiome of cancer patients and reported a positive association.

14 Nov 2022

New discovery reveals which patients will survive longer after receiving immunotherapy

Patients with head and neck cancer who have more genetic material on chromosome 9 in their cancer cells survive three times longer after receiving immunotherapy than those with less genetic material there, a new study finds.

14 Nov 2022

New scientific statement highlights the impact of telehealth in cardiovascular disease management

Telehealth is a proven and valuable option for people with cardiovascular disease, however, there are limitations to its use in rural and under-resourced communities, according to a new scientific statement from the American Heart Association, published today in the Association's flagship peer-reviewed journal Circulation.

14 Nov 2022

Study reveals the ability of smartwatch ECG to accurately detect heart failure

A study published in Nature Medicine reports the ability of a smartwatch ECG to accurately detect heart failure in nonclinical environments.

14 Nov 2022

Obese patients undergoing knee replacement have higher risk of revision surgery, study finds

University of Queensland research has revealed Australians undergoing a knee replacement operation are at a higher risk of needing further surgery if they're obese.

14 Nov 2022

New online tool launched to increase awareness and participation in Alzheimer’s clinical trials

Also at AAIC 2021, the National Institute on Aging (NIA), part of the U.S. National Institutes of Health, launched a new online tool, Outreach Pro, to help researchers and clinicians increase awareness and participation in clinical trials on Alzheimer's disease and other dementias, especially among traditionally underrepresented communities.

14 Nov 2022

Restorative neurostimulation continues to be effective in treating low-back pain for three years

A study has found that restorative neurostimulation continues to be effective in treating low-back pain caused by multifidus dysfunction after three years.

14 Nov 2022

High-intensity aerobic exercise can cut metastatic cancer risk by 72%

A new study at Tel Aviv University found that aerobic exercise can reduce the risk of metastatic cancer by 72%.

14 Nov 2022

Sleep deprivation associated with the occurrence and poor treatment outcomes of arrhythmias

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Sleep is essential to the normal psychological and physiological activities of the human body.

14 Nov 2022

Older adults suffer from persistent cognitive impairment after recovery from SARS-CoV-2 infection

In addition to the respiratory and gastrointestinal symptoms that accompany COVID-19, many people with the virus experience short- and/or long-term neuropsychiatric symptoms, including loss of smell and taste, and cognitive and attention deficits, known as "brain fog."

14 Nov 2022

Study assesses musculoskeletal health needs of underserved patients

To improve the health of a community, the first step is to identify its most pressing needs. To that end, in 2022 Hospital for Special Surgery (HSS) implemented a community-based participatory research (CBPR) approach to assess musculoskeletal health needs, identify health disparities and support the development of initiatives to address unmet needs.

14 Nov 2022

Study highlights the success of lupus peer support group that transitioned to virtual format during pandemic

A study at Hospital for Special Surgery highlights the success of a lupus peer support and education group that transitioned to a virtual format during the pandemic.

14 Nov 2022

Oral deucravacitinib shows promise in patients with active lupus

Tyrosine kinases are enzymes that play central roles in signaling by cytokines involved in the pathogenesis of autoimmune diseases, including lupus.

14 Nov 2022

First placebo-controlled long-term trial of anifrolumab shows positive results in patients with lupus

Type I interferon (IFN) is a powerful immune activator that is present at high levels in the majority of patients with lupus, an autoimmune disease. In Arthritis & Rheumatology, researchers report positive results from the first placebo-controlled long-term trial of anifrolumab - a human monoclonal antibody that targets the type I IFN receptor - in patients with lupus.

14 Nov 2022

World Diabetes Day 2022: The Importance of Type 1 Research and Awareness with JDRF

For World Diabetes Day 2022, News-Medical speaks to JDRF, the type 1 diabetes charity, about the importance of type 1 diabetes research and awareness, as well as dispelling the misconceptions behind this autoimmune condition.

14 Nov 2022

Medical Condition News

Brain-machine interfaces could one day help patients who have lost speaking ability

Mechanically active adhesive prevents and supports the recovery from muscle atrophy

PALS program effective in ensuring diverse representation in lupus clinical trials

Study highlights the complexity of health-care costs for ADRD patients who develop delirium

Mast cells in synovial tissue may explain why women report worse osteoarthritis pain than men

Study finds a positive impact of exercise on the gut microbiome of cancer patients

New discovery reveals which patients will survive longer after receiving immunotherapy

New scientific statement highlights the impact of telehealth in cardiovascular disease management

Study reveals the ability of smartwatch ECG to accurately detect heart failure

Obese patients undergoing knee replacement have higher risk of revision surgery, study finds

New online tool launched to increase awareness and participation in Alzheimer’s clinical trials

Restorative neurostimulation continues to be effective in treating low-back pain for three years

High-intensity aerobic exercise can cut metastatic cancer risk by 72%

Sleep deprivation associated with the occurrence and poor treatment outcomes of arrhythmias

Older adults suffer from persistent cognitive impairment after recovery from SARS-CoV-2 infection

Study assesses musculoskeletal health needs of underserved patients

Study highlights the success of lupus peer support group that transitioned to virtual format during pandemic

Oral deucravacitinib shows promise in patients with active lupus

First placebo-controlled long-term trial of anifrolumab shows positive results in patients with lupus

World Diabetes Day 2022: The Importance of Type 1 Research and Awareness with JDRF

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News